000 01450 a2200385 4500
005 20250517160054.0
264 0 _c20180608
008 201806s 0 0 eng d
022 _a1549-490X
024 7 _a10.1634/theoncologist.2017-0079
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAndersson, Michael
245 0 0 _aEfficacy and Safety of Pertuzumab and Trastuzumab Administered in a Single Infusion Bag, Followed by Vinorelbine: VELVET Cohort 2 Final Results.
_h[electronic resource]
260 _bThe oncologist
_c10 2017
300 _a1160-1168 p.
_bdigital
500 _aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study
650 0 4 _aAntibodies, Monoclonal, Humanized
_xpharmacology
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xpharmacology
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aTrastuzumab
_xpharmacology
650 0 4 _aTreatment Outcome
650 0 4 _aVinblastine
_xanalogs & derivatives
650 0 4 _aVinorelbine
700 1 _aLópez-Vega, José M
700 1 _aPetit, Thierry
700 1 _aZamagni, Claudio
700 1 _aEaston, Valerie
700 1 _aKamber, Julia
700 1 _aRestuccia, Eleonora
700 1 _aPerez, Edith A
773 0 _tThe oncologist
_gvol. 22
_gno. 10
_gp. 1160-1168
856 4 0 _uhttps://doi.org/10.1634/theoncologist.2017-0079
_zAvailable from publisher's website
999 _c27256614
_d27256614